Bastiaan Hoogendoorn at Cardiff University in the United Kingdom will develop a simple, inexpensive breath-testing device to measure the type and levels of bacteria in the lungs for rapid diagnosis of pneumonia in children in low-resource settings. Rather than condensing the exhaled breath, which can cause variation, the device directly captures respiratory fluid droplets containing non-volatile pathogen markers. These markers can then be identified using low-cost commercially available bioassay kits. They will analyze biomarker levels in the breath of sick and healthy children, and test and refine the design of their prototype.
More information about New Ways to Reduce Childhood Pneumonia Deaths Through Delivery of Timely Effective Treatment (Round 15)